Reactogenicity of live-attenuated Vibrio cholerae vaccines is dependent on flagellins
暂无分享,去创建一个
[1] F. Qadri,et al. Development of Peru-15 (CholeraGarde®), a live-attenuated oral cholera vaccine: 1991–2009 , 2009, Expert review of vaccines.
[2] F. Yildiz,et al. The Vibrio cholerae Flagellar Regulatory Hierarchy Controls Expression of Virulence Factors , 2009, Journal of bacteriology.
[3] V. Viswanathan,et al. Enteric infection meets intestinal function: how bacterial pathogens cause diarrhoea , 2009, Nature Reviews Microbiology.
[4] J. Kaper,et al. Vibrio cholerae Flagellins Induce Toll-Like Receptor 5-Mediated Interleukin-8 Production through Mitogen-Activated Protein Kinase and NF-κB Activation , 2008, Infection and Immunity.
[5] Jun Zhu,et al. Mucosal penetration primes Vibrio cholerae for host colonization by repressing quorum sensing , 2008, Proceedings of the National Academy of Sciences.
[6] C. Coban,et al. Host innate immune receptors and beyond: making sense of microbial infections. , 2008, Cell host & microbe.
[7] J. Holmgren,et al. Cholera toxin structure, gene regulation and pathophysiological and immunological aspects , 2008, Cellular and Molecular Life Sciences.
[8] J. Mekalanos,et al. Decreased Potency of the Vibrio cholerae Sheathed Flagellum To Trigger Host Innate Immunity , 2008, Infection and Immunity.
[9] A. Aderem,et al. TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system , 2007, Seminars in Immunopathology.
[10] M. Waldor,et al. RNase E-dependent processing stabilizes MicX, a Vibrio cholerae sRNA , 2007, Molecular microbiology.
[11] K. Klose,et al. Identification of Proinflammatory Flagellin Proteins in Supernatants of Vibrio cholerae O1 by Proteomics Analysis*S , 2006, Molecular & Cellular Proteomics.
[12] S. Calderwood,et al. Live attenuated oral cholera vaccines , 2006, Expert review of vaccines.
[13] M. Swanson,et al. Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection , 2006, The Journal of experimental medicine.
[14] W. Dietrich,et al. Flagellin-Deficient Legionella Mutants Evade Caspase-1- and Naip5-Mediated Macrophage Immunity , 2006, PLoS pathogens.
[15] M. Waldor,et al. Activation of the Vibrio cholerae SOS Response Is Not Required for Intestinal Cholera Toxin Production or Colonization , 2006, Infection and Immunity.
[16] C. Pothoulakis,et al. Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. Mathan,et al. Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut , 2003, Gut.
[18] P. Sansonetti,et al. The Contribution of Accessory Toxins of Vibrio cholerae O1 El Tor to the Proinflammatory Response in a Murine Pulmonary Cholera Model , 2002, The Journal of experimental medicine.
[19] John F. Heidelberg,et al. Comparative genomic analysis of Vibrio cholerae: Genes that correlate with cholera endemic and pandemic disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[20] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[21] Z. Dossani,et al. Directed polar secretion of protease from single cells of Vibrio cholerae via the type II secretion pathway , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[22] C. Häse,et al. Flagellum-Independent Surface Migration ofVibrio cholerae and Escherichia coli , 2001, Journal of bacteriology.
[23] S. Calderwood,et al. Cholera vaccines. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] J. Mekalanos,et al. Copyright © 1998, American Society for Microbiology Differential Regulation of Multiple Flagellins in Vibrio cholerae , 1997 .
[25] C. Tacket,et al. New evidence for an inflammatory component in diarrhea caused by selected new, live attenuated cholera vaccines and by El Tor and Q139 Vibrio cholerae , 1996, Infection and immunity.
[26] J. Mekalanos,et al. Alterations in Vibrio cholerae motility phenotypes correlate with changes in virulence factor expression , 1996, Infection and immunity.
[27] J. Kaper,et al. Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. , 1996, Microbiological reviews.
[28] D. Spriggs,et al. Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1. , 1995, The Journal of infectious diseases.
[29] J. Ezzell,et al. Development of a live, oral, attenuated vaccine against El Tor cholera. , 1994, The Journal of infectious diseases.
[30] J. Mekalanos,et al. Cholera vaccines: fighting an ancient scourge. , 1994, Science.
[31] Amit Pal,et al. Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India , 1993, The Lancet.
[32] J. Mekalanos,et al. Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development , 1983, Nature.